Your browser doesn't support javascript.
loading
Correlation of AR, EGFR, and HER2 Expression Levels in Prostate Cancer: Immunohistochemical Analysis and Chromogenic In Situ Hybridization / Journal of the Korean Cancer Association, 대한암학회지
Cancer Research and Treatment ; : 50-56, 2012.
Article Dans Anglais | WPRIM | ID: wpr-213349
ABSTRACT

PURPOSE:

The androgen receptor (AR) plays a central role in prostate cancer. Evidence from several groups indicates that epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor 2 (HER2) may enhance AR activity in prostate cancer cell lines. This study was designed to investigate the protein expression of AR, EGFR, and HER2 and to determine whether the EGFR and HER2 genes are amplified in prostate cancer tissues. MATERIALS AND

METHODS:

The protein expression levels of AR, EGFR, and HER2 in a tissue microarray block of 66 prostate cancer samples were investigated by immunohistochemical analysis and chromogenic in situ hybridization was used to determine whether the EGFR and HER2 genes were amplified in these tissues.

RESULTS:

The AR and EGFR proteins were expressed in 59.1% and 40.9% of prostate cancers, respectively, but their expression levels were not significantly associated with clinicopathologic factors. Of the cases in which tissues were negative for EGFR protein expression, 69.2% were positive for AR protein expression; however, AR protein expression was significantly reduced (44.4%) in tissues in which EGFR protein was expressed. HER2 expression was detected in only 1 case (1.5%). No amplification of the EGFR or HER2 genes was found in prostate cancer specimens.

CONCLUSION:

This study was limited by small number of subjects, but it can still be inferred that the expression levels of the AR and EGFR proteins are inversely correlated in prostate cancer patients. The potential utility of EGFR and HER2 as prognostic factors or therapeutic targets warrants further study.
Sujets)

Texte intégral: Disponible Indice: WPRIM (Pacifique occidental) Sujet Principal: Prostate / Tumeurs de la prostate / Protéines / Récepteurs aux androgènes / Lignée cellulaire / Hybridation in situ / Récepteur ErbB-2 / Gènes erbB-2 / Récepteurs ErbB Type d'étude: Étude pronostique Limites du sujet: Humains langue: Anglais Texte intégral: Cancer Research and Treatment Année: 2012 Type: Article

Documents relatifs à ce sujet

MEDLINE

...
LILACS

LIS

Texte intégral: Disponible Indice: WPRIM (Pacifique occidental) Sujet Principal: Prostate / Tumeurs de la prostate / Protéines / Récepteurs aux androgènes / Lignée cellulaire / Hybridation in situ / Récepteur ErbB-2 / Gènes erbB-2 / Récepteurs ErbB Type d'étude: Étude pronostique Limites du sujet: Humains langue: Anglais Texte intégral: Cancer Research and Treatment Année: 2012 Type: Article